← Leaderboards
Leonidas C Platanias
University Of Illinois At Chicago
$52,051,461
Attributed
$55,053,953
Total exposure
42
Grants
39
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$145,792,449 · 43
VA$0 · 1
By mechanism
P30$107,714,129 · 29
R01$22,474,343 · 10
U54$11,714,382 · 1
T32$3,765,165 · 1
R29$109,430 · 1
U13$15,000 · 1
Top collaborators
- Gary E Schiltz8 shared
- Chad A. Mirkin5 shared
- Charles David James4 shared
- Richard J Miller3 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Randal A Skidgel$17,036,703
- Asrar B. Malik$58,182,625
- You-Yang Zhao$24,398,532
- R John Solaro$27,541,486
- Liang Hong$2,121,794
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsComprehensive Cancer CenterResearch PersonnelProgramsCancer CenterBaseMemberUniversitiesResourcesFundingMolecularSignal TransductionResource SharingLaboratoriesCancer Center Support GrantClinical ResearchPathway InteractionsTrainingMissionGrowthInstructionTranslational ResearchResponseFaculty
Grant awards (200)
The Robert H. Lurie Comprehensive Cancer Center$6,423,784
P30 · FY2025 · CA · contact PI
Leadership, Planning and Evaluation$768,242
P30 · FY2025 · CA · contact PI
Training Program in Signal Transduction and Cancer$307,553
T32 · FY2025 · CA · contact PI
Signaling Pathways and Therapeutic Targeting of Leukemic Cells$0
I01 · FY2025 · VA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$6,280,676
P30 · FY2024 · CA · contact PI
Leadership, Planning and Evaluation$693,467
P30 · FY2024 · CA · contact PI
Developmental Funds$410,800
P30 · FY2024 · CA · contact PI
Signal Transduction of Type 1 Interferons in Malignant Cells$342,000
R01 · FY2024 · CA · contact PI
Training Program in Signal Transduction and Cancer$308,619
T32 · FY2024 · CA · contact PI
Early Career Cancer Clinical Investigator Award for Fiscal Year (FY) 2024$59,992
P30 · FY2024 · CA · contact PI
Signaling Pathways and Therapeutic Targeting of Leukemic Cells$0
I01 · FY2024 · VA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$6,280,676
P30 · FY2023 · CA · contact PI
Leadership, Planning and Evaluation$693,467
P30 · FY2023 · CA · contact PI
Development of Novel MNK Inhibitors for Treating Glioblastoma$501,170
R01 · FY2023 · NS · contact PI
Developmental Funds$410,800
P30 · FY2023 · CA · contact PI
Signal Transduction of Type 1 Interferons in Malignant Cells$360,000
R01 · FY2023 · CA · contact PI
SLFN5: A Novel Therapeutic Target for Glioblastoma$345,625
R01 · FY2023 · NS · contact PI
Training Program in Signal Transduction and Cancer$300,757
T32 · FY2023 · CA · contact PI
Targeting Novel Protein Complexes for the Treatment of Acute Myeloid Leukemia$300,200
R01 · FY2023 · CA · contact PI
Social Determinants of Health and Quality of Cancer Care in HIV-associated Cancers$247,704
P30 · FY2023 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$6,280,670
P30 · FY2022 · CA · contact PI
Leadership, Planning and Evaluation$665,729
P30 · FY2022 · CA · contact PI
Developmental Funds$615,923
P30 · FY2022 · CA · contact PI
Development of Novel MNK Inhibitors for Treating Glioblastoma$501,170
R01 · FY2022 · NS · contact PI
Signal Transduction of Type 1 Interferons in Malignant Cells$352,800
R01 · FY2022 · CA · contact PI
SLFN5: A Novel Therapeutic Target for Glioblastoma$345,625
R01 · FY2022 · NS · contact PI
Targeting Novel Protein Complexes for the Treatment of Acute Myeloid Leukemia$294,196
R01 · FY2022 · CA · contact PI
Implementing Sex, Sexual Orientation, and Gender Identity (SSOGI) Data Collection in Cancer Care (SSOGI Collect)$108,535
P30 · FY2022 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$6,280,670
P30 · FY2021 · CA · contact PI
Leadership, Planning and Evaluation$665,729
P30 · FY2021 · CA · contact PI
Developmental Funds$615,923
P30 · FY2021 · CA · contact PI
Development of Novel MNK Inhibitors for Treating Glioblastoma$501,170
R01 · FY2021 · NS · contact PI
Signal Transduction of Type 1 Interferons in Malignant Cells$358,500
R01 · FY2021 · CA · contact PI
SLFN5: A Novel Therapeutic Target for Glioblastoma$345,625
R01 · FY2021 · NS · contact PI
Implementation and Evaluation at Northwestern Medicine of Shareable EHR Treatment Plans in support of Multi-Site Clinical Trials$302,248
P30 · FY2021 · CA · contact PI
Targeting Novel Protein Complexes for the Treatment of Acute Myeloid Leukemia$300,200
R01 · FY2021 · CA · contact PI
Training Program in Signal Transduction and Cancer$290,269
T32 · FY2021 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$125,000
P30 · FY2021 · CA · contact PI
Signaling Pathways and Therapeutic Targeting of Leukemic Cells$0
I01 · FY2021 · VA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$6,280,670
P30 · FY2020 · CA · contact PI
Leadership, Planning and Evaluation$665,729
P30 · FY2020 · CA · contact PI
Developmental Funds$615,923
P30 · FY2020 · CA · contact PI
Development of Novel MNK Inhibitors for Treating Glioblastoma$501,170
R01 · FY2020 · NS · contact PI
Production of protein array for serum antibody screening$395,000
P30 · FY2020 · CA · contact PI
Signal Transduction of Type 1 Interferons in Malignant Cells$355,500
R01 · FY2020 · CA · contact PI
SLFN5: A Novel Therapeutic Target for Glioblastoma$345,625
R01 · FY2020 · NS · contact PI
Targeting Novel Protein Complexes for the Treatment of Acute Myeloid Leukemia$300,200
R01 · FY2020 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$298,623
P30 · FY2020 · CA · contact PI
Training Program in Signal Transduction and Cancer$287,598
T32 · FY2020 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$191,000
P30 · FY2020 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$150,000
P30 · FY2020 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$150,000
P30 · FY2020 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$125,000
P30 · FY2020 · CA · contact PI
Signaling Pathways and Therapeutic Targeting of Leukemic Cells$0
I01 · FY2020 · VA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$6,280,670
P30 · FY2019 · CA · contact PI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,278,098
U54 · FY2019 · CA
Leadership, Planning and Evaluation$665,729
P30 · FY2019 · CA · contact PI
Developmental Funds$615,923
P30 · FY2019 · CA · contact PI
Development of Novel MNK Inhibitors for Treating Glioblastoma$507,687
R01 · FY2019 · NS · contact PI
SLFN5: A Novel Therapeutic Target for Glioblastoma$345,625
R01 · FY2019 · NS · contact PI
Targeting Novel Protein Complexes for the Treatment of Acute Myeloid Leukemia$300,200
R01 · FY2019 · CA · contact PI
Training Program in Signal Transduction and Cancer$261,669
T32 · FY2019 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$250,000
P30 · FY2019 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$244,589
P30 · FY2019 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$200,000
P30 · FY2019 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$99,879
P30 · FY2019 · CA · contact PI
Signaling Pathways and Therapeutic Targeting of Leukemic Cells$0
I01 · FY2019 · VA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$6,420,169
P30 · FY2018 · CA · contact PI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,362,180
U54 · FY2018 · CA
Leadership, Planning and Evaluation$678,947
P30 · FY2018 · CA · contact PI
Developmental Funds$628,152
P30 · FY2018 · CA · contact PI
Training Program in Signal Transduction and Cancer$266,563
T32 · FY2018 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$250,000
P30 · FY2018 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$246,169
P30 · FY2018 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$200,000
P30 · FY2018 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$58,383
P30 · FY2018 · CA · contact PI
Developmental Funds$8,620
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$8,620
P30 · FY2018 · CA · contact PI
Developmental Funds$8,488
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$8,488
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$6,896
P30 · FY2018 · CA · contact PI
Developmental Funds$6,896
P30 · FY2018 · CA · contact PI
Signaling Pathways and Therapeutic Targeting of Leukemic Cells$0
I01 · FY2018 · VA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$4,865,652
P30 · FY2017 · CA · contact PI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,318,682
U54 · FY2017 · CA
SENIOR LEADERSHIP$568,830
P30 · FY2017 · CA · contact PI
Small molecule CXCR4 modulators as molecular probes for studying AML$513,581
R01 · FY2017 · CA
Administration$506,130
P30 · FY2017 · CA · contact PI
Development Funds$427,352
P30 · FY2017 · CA · contact PI
CLINICAL RESEARCH OFFICE$423,168
P30 · FY2017 · CA · contact PI
Program Leaders of Research Programs$378,822
P30 · FY2017 · CA · contact PI
BIOSTATISTICS CORE FACILITY$302,263
P30 · FY2017 · CA · contact PI
Signal Transduction of Type 1 Interferons in Malignant Cells$298,913
R01 · FY2017 · CA · contact PI
PATHOLOGY CORE FACILITY$272,075
P30 · FY2017 · CA · contact PI
Training Program in Signal Transduction and Cancer$247,337
T32 · FY2017 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$204,369
P30 · FY2017 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$183,762
P30 · FY2017 · CA · contact PI
Molecular & Translational Imaging Core$160,055
P30 · FY2017 · CA · contact PI
STRUCTURAL BIOLOGY FACILITY$159,571
P30 · FY2017 · CA · contact PI
Keck Biophysics Facility$157,428
P30 · FY2017 · CA · contact PI
TRANSGENIC AND TARGETED MUTAGENESIS LABORATORY$145,747
P30 · FY2017 · CA · contact PI
Cell Imaging Facility$143,123
P30 · FY2017 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$138,054
P30 · FY2017 · CA · contact PI
CANCER INFORMATICS CORE$134,896
P30 · FY2017 · CA · contact PI
High Throughput Analysis Laboratory$134,391
P30 · FY2017 · CA · contact PI
Developmental Therapeutics Core Facility$134,072
P30 · FY2017 · CA · contact PI
MOUSE HISTOLOGY & PHENOTYPING LABORATORY$131,098
P30 · FY2017 · CA · contact PI
Flow Cytometry Facility$123,906
P30 · FY2017 · CA · contact PI
Medicinal & Synthetic Chemistry Core$100,933
P30 · FY2017 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$79,482
P30 · FY2017 · CA · contact PI
OUTCOMES MEASUREMENT & SURVEY CORE FACILITY$67,916
P30 · FY2017 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$57,797
P30 · FY2017 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$36,427
P30 · FY2017 · CA · contact PI
PLANNING AND EVALUATION$35,633
P30 · FY2017 · CA · contact PI
Training Program in Signal Transduction and Cancer$3,924
T32 · FY2017 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$4,865,180
P30 · FY2016 · CA · contact PI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,423,115
U54 · FY2016 · CA
SENIOR LEADERSHIP$568,775
P30 · FY2016 · CA · contact PI
Small molecule CXCR4 modulators as molecular probes for studying AML$539,886
R01 · FY2016 · CA
Administration$506,081
P30 · FY2016 · CA · contact PI
Development Funds$427,311
P30 · FY2016 · CA · contact PI
CLINICAL RESEARCH OFFICE$423,127
P30 · FY2016 · CA · contact PI
Program Leaders of Research Programs$378,785
P30 · FY2016 · CA · contact PI
BIOSTATISTICS CORE FACILITY$302,233
P30 · FY2016 · CA · contact PI
Signal Transduction of Type 1 Interferons in Malignant Cells$298,913
R01 · FY2016 · CA · contact PI
PATHOLOGY CORE FACILITY$272,047
P30 · FY2016 · CA · contact PI
Arsenic Trioxide activated pathways in malignant cells$266,285
R01 · FY2016 · CA · contact PI
Training Program in Signal Transduction and Cancer$249,080
T32 · FY2016 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$202,481
P30 · FY2016 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$183,744
P30 · FY2016 · CA · contact PI
Molecular & Translational Imaging Core$160,040
P30 · FY2016 · CA · contact PI
STRUCTURAL BIOLOGY FACILITY$159,556
P30 · FY2016 · CA · contact PI
Keck Biophysics Facility$157,413
P30 · FY2016 · CA · contact PI
TRANSGENIC AND TARGETED MUTAGENESIS LABORATORY$145,733
P30 · FY2016 · CA · contact PI
Cell Imaging Facility$143,109
P30 · FY2016 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$138,041
P30 · FY2016 · CA · contact PI
CANCER INFORMATICS CORE$134,883
P30 · FY2016 · CA · contact PI
High Throughput Analysis Laboratory$134,378
P30 · FY2016 · CA · contact PI
Developmental Therapeutics Core Facility$134,059
P30 · FY2016 · CA · contact PI
MOUSE HISTOLOGY & PHENOTYPING LABORATORY$131,084
P30 · FY2016 · CA · contact PI
Flow Cytometry Facility$123,894
P30 · FY2016 · CA · contact PI
Medicinal & Synthetic Chemistry Core$100,923
P30 · FY2016 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$79,482
P30 · FY2016 · CA · contact PI
OUTCOMES MEASUREMENT & SURVEY CORE FACILITY$67,910
P30 · FY2016 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$36,424
P30 · FY2016 · CA · contact PI
PLANNING AND EVALUATION$35,630
P30 · FY2016 · CA · contact PI
Signaling Pathways and Therapeutic Targeting of Leukemic Cells$0
I01 · FY2016 · VA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$4,814,560
P30 · FY2015 · CA · contact PI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer$2,332,307
U54 · FY2015 · CA
SENIOR LEADERSHIP$562,756
P30 · FY2015 · CA · contact PI
Small molecule CXCR4 modulators as molecular probes for studying AML$529,121
R01 · FY2015 · CA
Administration$500,915
P30 · FY2015 · CA · contact PI
Development Funds$422,941
P30 · FY2015 · CA · contact PI
CLINICAL RESEARCH OFFICE$418,800
P30 · FY2015 · CA · contact PI
Program Leaders of Research Programs$374,906
P30 · FY2015 · CA · contact PI
Mnk Pathways and IFN-responses in Malignant Cells$316,438
R01 · FY2015 · CA · contact PI
Interferon-induced SLFNs and tumorigenesis$316,438
R01 · FY2015 · CA · contact PI
BIOSTATISTICS CORE FACILITY$299,127
P30 · FY2015 · CA · contact PI
Signal Transduction of Type 1 Interferons in Malignant Cells$298,913
R01 · FY2015 · CA · contact PI
PATHOLOGY CORE FACILITY$269,246
P30 · FY2015 · CA · contact PI
Arsenic Trioxide activated pathways in malignant cells$266,285
R01 · FY2015 · CA · contact PI
Training Program in Signal Transduction and Cancer$216,281
T32 · FY2015 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$181,834
P30 · FY2015 · CA · contact PI
Molecular & Translational Imaging Core$158,367
P30 · FY2015 · CA · contact PI
STRUCTURAL BIOLOGY FACILITY$157,889
P30 · FY2015 · CA · contact PI
Keck Biophysics Facility$155,768
P30 · FY2015 · CA · contact PI
TRANSGENIC AND TARGETED MUTAGENESIS LABORATORY$144,206
P30 · FY2015 · CA · contact PI
Cell Imaging Facility$141,607
P30 · FY2015 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$136,592
P30 · FY2015 · CA · contact PI
CANCER INFORMATICS CORE$133,466
P30 · FY2015 · CA · contact PI
High Throughput Analysis Laboratory$132,965
P30 · FY2015 · CA · contact PI
Developmental Therapeutics Core Facility$132,649
P30 · FY2015 · CA · contact PI
MOUSE HISTOLOGY & PHENOTYPING LABORATORY$129,706
P30 · FY2015 · CA · contact PI
Flow Cytometry Facility$122,587
P30 · FY2015 · CA · contact PI
Medicinal & Synthetic Chemistry Core$99,849
P30 · FY2015 · CA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$79,482
P30 · FY2015 · CA · contact PI
OUTCOMES MEASUREMENT & SURVEY CORE FACILITY$67,168
P30 · FY2015 · CA · contact PI
DATA AND SAFETY MONITORING/NIH POLICY$36,001
P30 · FY2015 · CA · contact PI
PLANNING AND EVALUATION$35,215
P30 · FY2015 · CA · contact PI
Signaling Pathways and Therapeutic Targeting of Leukemic Cells$0
I01 · FY2015 · VA · contact PI
The Robert H. Lurie Comprehensive Cancer Center$4,686,132
P30 · FY2014 · CA · contact PI
SENIOR LEADERSHIP$533,400
P30 · FY2014 · CA · contact PI
Administration$474,639
P30 · FY2014 · CA · contact PI
Development Funds$400,762
P30 · FY2014 · CA · contact PI
CLINICAL RESEARCH OFFICE$396,841
P30 · FY2014 · CA · contact PI
Program Leaders of Research Programs$355,250
P30 · FY2014 · CA · contact PI
Mnk Pathways and IFN-responses in Malignant Cells$306,945
R01 · FY2014 · CA · contact PI
Interferon-induced SLFNs and tumorigenesis$306,945
R01 · FY2014 · CA · contact PI
Signal Transduction of Type 1 Interferons in Malignant Cells$289,946
R01 · FY2014 · CA · contact PI
BIOSTATISTICS CORE FACILITY$283,456
P30 · FY2014 · CA · contact PI
Arsenic Trioxide activated pathways in malignant cells$258,296
R01 · FY2014 · CA · contact PI
PATHOLOGY CORE FACILITY$255,142
P30 · FY2014 · CA · contact PI
Training Program in Signal Transduction and Cancer$219,962
T32 · FY2014 · CA · contact PI
PROTOCOL-SPECIFIC RESEARCH SUPPORT$172,324
P30 · FY2014 · CA · contact PI
Molecular & Translational Imaging Core$150,090
P30 · FY2014 · CA · contact PI
STRUCTURAL BIOLOGY FACILITY$149,637
P30 · FY2014 · CA · contact PI
Keck Biophysics Facility$147,627
P30 · FY2014 · CA · contact PI
TRANSGENIC AND TARGETED MUTAGENESIS LABORATORY$136,675
P30 · FY2014 · CA · contact PI
Cell Imaging Facility$134,209
P30 · FY2014 · CA · contact PI
PROTOCOL REVIEW AND MONITORING SYSTEM$129,458
P30 · FY2014 · CA · contact PI